# Gladstone Investment Corporation\\de: overview GAIN · Nasdaq · CIK 1321741 · [Other](/sectors/other.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/gain.md) · [Financials](/companies/gain/financials.md) · [Filings](/companies/gain/filings.md) · [Insiders](/companies/gain/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.20](/filings/0001321741-24-000017.md) | [0.03](/filings/0001321741-25-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.45](/filings/0001321741-24-000009.md) | [1.11](/filings/0001321741-25-000010.md) | [0.63](/filings/0001321741-25-000010.md) | [0.76](/filings/0001321741-25-000010.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gain/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $12.4m | 804,098 | | Added +212,170 | | [Melia Wealth LLC](/funds/1964047.md) | 2026-06-30 | $10.1m | 656,313 | | Reduced −413,173 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $9.6m | 618,149 | | Reduced −114,082 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $9.0m | 584,106 | | Reduced −220,157 | | [Union Bancaire Privee, UBP SA](/funds/1716607.md) | 2026-06-30 | $8.8m | 3,570 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $5.4m | 349,848 | | Added +11,776 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $5.2m | 337,067 | | Added +36,369 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $3.9m | 254,000 | Call | New +254,000 | | [PFG Advisors](/funds/1694435.md) | 2026-06-30 | $3.7m | 236,628 | | Reduced −78,702 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.4m | 220,759 | | Added +13,356 | ## Recent filings [All 735 filings](/companies/gain/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:20 ET | [8-K](/filings/0001193125-26-431974.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-431974 | | 2026-10-01 | 16:05 ET | [8-K](/filings/0001193125-26-410647.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-410647 | | 2026-09-04 | 16:07 ET | [8-K](/filings/0001193125-26-383646.md) | 5.07 Shareholder vote results | 0001193125-26-383646 | | 2026-08-06 | 16:19 ET | [8-K](/filings/0001321741-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321741-26-000018 | | 2026-08-06 | 16:15 ET | [8-K](/filings/0001193125-26-338057.md) | 5.07 Shareholder vote results | 0001193125-26-338057 | | 2026-08-06 | 16:11 ET | [10-Q](/filings/0001321741-26-000017.md) | Quarterly report, period 2026-06-30 | 0001321741-26-000017 | | 2026-07-08 | 18:30 ET | [8-K](/filings/0001193125-26-297752.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-297752 | | 2026-06-18 | 08:30 ET | [DEF 14A](/filings/0001193125-26-275045.md) | Proxy statement, period 2026-08-06 | 0001193125-26-275045 | | 2026-06-11 | 16:05 ET | [8-K](/filings/0001193125-26-267511.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-267511 | | 2026-06-02 | 08:45 ET | [8-K](/filings/0001193125-26-252618.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-252618 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001321741-26-000011.md), filed May 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1321741 - Tickers: GAIN, GAING, GAINI, GAINZ - Exchange: Nasdaq - SIC code: not reported - State of incorporation: DE - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:21 ET. No prices; not investment advice.